Latest Articles

  • Whether to anticoagulate: Toward a more reasoned approach
    Theodore T. Suh, MD, PhD, MHS
    Cleveland Clinic Journal of Medicine January 2017, 84 (1) 41-42; DOI: https://doi.org/10.3949/ccjm.84a.16086

    The patient’s life expectancy and personal preferences are important and affect the decision.

  • Big heart, small ring
    Igor Kravets, MD, FACE
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 925-933; DOI: https://doi.org/10.3949/ccjm.84a.16101

    A 58-year-old man has stopped wearing his wedding ring, and his wife suspects him of having an extramarital affair.

  • Porcelain heart in a uremic patient
    Hsiu-Chien Yang, MD, Chang-Han Lo, MD, Chun-Chi Chen, MD and Chia-Chao Wu, MD, PhD
    Cleveland Clinic Journal of Medicine March 2017, 84 (3) 184-185; DOI: https://doi.org/10.3949/ccjm.84a.15177

    Constrictive pericarditis due to secondary hyperparathyroidism occurs in up to 4% of patients with end-stage renal disease.

  • Thrombolysis in submassive pulmonary embolism: Finding the balance
    Carlos L. Alviar, MD and Gustavo A. Heresi, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 933-936; DOI: https://doi.org/10.3949/ccjm.83a.16099

    In massive pulmonary embolism, thrombolytic therapy is usually indicated; in submassive cases the decision is not so clear.

  • Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
    Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
    Ali Ataya, MD, Jessica Cope, PharmD, Abbas Shahmohammadi, MD and Hassan Alnuaimat, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 923-932; DOI: https://doi.org/10.3949/ccjm.83a.15116

    The risk of hemorrhage is signifi cant, and the benefi t is unclear. A one-treatment-for-all approach cannot be applied.

  • Women’s health 2016: An update for internists
    Pelin Batur, MD, NCMP, CCD, Eleanor Bimla Schwarz, MD, MS, Judith M. E. Walsh, MD, MPH and Kay M. Johnson, MD, MPH
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 905-913; DOI: https://doi.org/10.3949/ccjm.83a.16098

    Important studies of urinary tract infections, bisphosphonates, ovarian cancer screening, and contraception.

  • When should an indwelling pleural catheter be considered for malignant pleural effusion?
    Abdul Hamid Alraiyes, MD, FCCP, Kassem Harris, MD, FCCP and Thomas R. Gildea, MD, MS, FCCP
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 891-894; DOI: https://doi.org/10.3949/ccjm.83a.15075

    Consider catheter placement if symptoms and effusions recur or if pleurodesis fails.

  • Abdominal pain under immunosuppressive conditions
    Takayo Ota, MD, PhD, Masanobu Nakano, MSc, Noriko Tanaka, MD, Tomohiro Suzumura, MD, PhD, Nozomi Miyatake, BPharm, Yoshikazu Hasegawa, MD, PhD, Tomohiro Ozaki, MD, Hiroshi Tsukuda, MD and Masahiro Fukuoka, MD, PhD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 874-875; DOI: https://doi.org/10.3949/ccjm.83a.15143

    A cancer patient receiving corticosteroids for a brain metastasis developed emphysematous cystitis and psoas muscle abscess.

  • Taurine, energy drinks, and neuroendocrine effects
    Jonathan J. Caine, MD and Thomas D. Geracioti, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 895-904; DOI: https://doi.org/10.3949/ccjm.83a.15050

    Taurine is a major ingredient in popular energy drinks, but little is known about its neuroendocrine effects.

  • Hiding in clear sight: Complications of immunosuppressive therapies
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 862-863; DOI: https://doi.org/10.3949/ccjm.83b.12016

    Immunosuppressive drugs can mask the signs of deep infection and thus delay its diagnosis.

Pages